Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)
China flag China · Delayed Price · Currency is CNY
11.86
-0.12 (-1.00%)
Apr 30, 2026, 3:00 PM CST

SHA:603811 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
788.8712.31669.61653.25693.45757.43
Other Revenue
2.062.062.011.720.520.7
790.86714.37671.63654.97693.96758.13
Revenue Growth (YoY)
7.94%6.36%2.54%-5.62%-8.46%11.29%
Cost of Revenue
237.27225.17248.45217.8208.98206.41
Gross Profit
553.59489.2423.17437.17484.99551.72
Selling, General & Admin
325.25308.66246.92269.61280.27344.57
Research & Development
41.8647.0847.1444.339.7231.79
Other Operating Expenses
15.7212.347.467.7710.79.68
Operating Expenses
381.9365.77302.46321.83331.21387.13
Operating Income
171.69123.43120.71115.34153.78164.59
Interest Expense
-4.47-11.09-15.26-9.13-4.52-4.96
Interest & Investment Income
40.5746.2867.1249.0831.8724.36
Currency Exchange Gain (Loss)
0.010.01-0.173.455.36-0.62
Other Non Operating Income (Expenses)
-2.08-0.07-0.31-0.11-0.99-0.21
EBT Excluding Unusual Items
205.71158.56172.1158.62185.49183.16
Impairment of Goodwill
----2.42-2.92-4.92
Gain (Loss) on Sale of Investments
----3.5510.69-
Gain (Loss) on Sale of Assets
60.8969.17-00.06-0.450
Asset Writedown
-27.65-24-7.47-0.41-0.5-3.21
Other Unusual Items
12.7714.49.4411.535.1913.86
Pretax Income
251.72218.13174.06163.84197.5188.89
Income Tax Expense
23.3317.3512.012.6626.2723.94
Earnings From Continuing Operations
228.38200.79162.05161.18171.23164.95
Minority Interest in Earnings
-2.03-0.090.850.4-0.430.19
Net Income
226.35200.7162.9161.58170.8165.14
Net Income to Common
226.35200.7162.9161.58170.8165.14
Net Income Growth
36.34%23.21%0.81%-5.39%3.42%25.69%
Shares Outstanding (Basic)
323329326330328326
Shares Outstanding (Diluted)
323329326330328326
Shares Change (YoY)
-0.78%0.99%-1.20%0.67%0.59%-0.09%
EPS (Basic)
0.700.610.500.490.520.51
EPS (Diluted)
0.700.610.500.490.520.51
EPS Growth
37.41%22.00%2.04%-6.02%2.82%25.80%
Free Cash Flow
275.95145.83123.93-86.929.3834.13
Free Cash Flow Per Share
0.850.440.38-0.260.030.10
Dividend Per Share
0.2500.2500.2000.1790.1790.179
Dividend Growth
25.00%25.00%11.98%--22.50%
Gross Margin
70.00%68.48%63.01%66.75%69.89%72.77%
Operating Margin
21.71%17.28%17.97%17.61%22.16%21.71%
Profit Margin
28.62%28.09%24.25%24.67%24.61%21.78%
Free Cash Flow Margin
34.89%20.41%18.45%-13.27%1.35%4.50%
EBITDA
279.18217.99198.04176.89208.45212.46
EBITDA Margin
35.30%30.52%29.49%27.01%30.04%28.02%
D&A For EBITDA
107.594.5677.3261.5554.6747.87
EBIT
171.69123.43120.71115.34153.78164.59
EBIT Margin
21.71%17.28%17.97%17.61%22.16%21.71%
Effective Tax Rate
9.27%7.95%6.90%1.62%13.30%12.68%
Revenue as Reported
605.27714.37671.63654.97693.96758.13
Advertising Expenses
-3.851.810.891.411.41
Source: S&P Global Market Intelligence. Standard template. Financial Sources.